Patents Assigned to Hutchison
  • ANDROGRAPHIS EXTRACT FORMULATIONS
    Publication number: 20110142944
    Abstract: A pharmaceutical formulation containing 50-90% by weight a powdered extract of Andrographis paniculata and 5-50% by weight a powdered blocking agent. The formulation may further contain a pore-forming agent, a filler, a lubricant, or a glidant. Also described are a method for preparing this pharmaceutical formulation and a method for treating inflammatory disease, immunological disease, or respiratory disease with it.
    Type: Application
    Filed: December 15, 2010
    Publication date: June 16, 2011
    Applicant: Hutchison Medipharma Enterprises Limited, Offshore Group Chambers
    Inventors: Yuqing Wang, Li Wang, Xun Zhang
  • Decahydronaphthalene compounds
    Patent number: 7902359
    Abstract: This invention relates to a compound of the following formula: wherein R1, R2, R3, G, and Z are defined herein. It also relates to is methods of treating autoimmune disease, cancer, and atherosclerosis with such a compound.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: March 8, 2011
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Tao Wang, Weihan Zhang, Xiaoqiang Yan, Weiguo Su, Jifeng Duan, Yu Cai
  • Cytokine inhibitors
    Patent number: 7868001
    Abstract: A compound of Formula I: Each variable is defined in the specification. This invention relates to a method of decreasing a level of a cytokine (e.g., TNF? or interlukine such as IL-1?) in a subject with a compound of Formula I. It also relates to a method of treating a disorder mediated by an overproduction of a cytokine with such a compound.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: January 11, 2011
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei Deng, Wei-Guo Su, Yu Cai, Jeff Duan
  • Substituted quinazoline compounds and their use in treating angiogenesis-related diseases
    Patent number: 7829574
    Abstract: Substituted quinazoline compounds of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and X are defined herein. It also discloses a pharmaceutical composition containing one of these compounds.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: November 9, 2010
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Pyrimidine compounds
    Patent number: 7737157
    Abstract: Pyrimidine compounds of the following formula: wherein R1, R2, R3, R4, R5, X, Q1, Q2, and Q3 are defined herein. Also disclosed is a method of treating cancer with one of these compounds.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: June 15, 2010
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Rick B. Ye, Yang Sai
  • PYRIMIDINE COMPOUNDS
    Publication number: 20100056512
    Abstract: Pyrimidine compounds of the following formula: wherein R1, R2, R3, R4, R5, X, Q1, Q2, and Q3 are defined herein. Also disclosed is a method of treating cancer with one of these compounds.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 4, 2010
    Applicant: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Rick B. Ye, Yang Sai
  • QUINAZOLINE DERIVATIVES
    Publication number: 20100009958
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, X, Y, and Z are defined herein. It also discloses a method of treating cancer with one of these compounds.
    Type: Application
    Filed: June 30, 2008
    Publication date: January 14, 2010
    Applicant: Hutchison MediPharma Enterprises Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • Traffic signal with integrated sensors
    Patent number: 7642928
    Abstract: A traffic signal including a housing, a light source disposed within the housing, and a door operably attached to the housing. The door is configured such that photons generated by the light source may be sensed outside the housing. The traffic signal also includes a sensor attached to one of the door and the housing.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: January 5, 2010
    Assignee: M&K Hutchison Investments, LP
    Inventor: Michael Cole Hutchison
  • Andrographolide and analogues as inhibitors of TNF? and IL-1? expression
    Patent number: 7625945
    Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: December 1, 2009
    Assignee: Hutchison MediPharma Enterprises Ltd.
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai
  • Costunolide derivatives
    Patent number: 7622465
    Abstract: Disclosed are methods for inhibiting TNF? expression, IL-1? expression, iNOS expression, and NF-?B activity and methods for treating autoimmune disease, cancer, or atherosclerosis with a compound of the following formula:
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: November 24, 2009
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Xiaoqiang Yan, Jifeng Duan, Tao Wang, Yu Cai, Weihan Zhang
  • QUINAZOLINE DERIVATIVES
    Publication number: 20090281130
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Application
    Filed: May 9, 2008
    Publication date: November 12, 2009
    Applicant: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS
    Publication number: 20090203770
    Abstract: The present invention provides agents and compositions for modulating the apoptotic state of a cell. The agents comprise derivatives of antimycins which bind to an anti-apoptotic Bcl-2 family member protein. Further, the agents preferentially induce apoptosis in cells that over-express anti-apoptotic Bcl-2 family member proteins and typically exhibit reduced binding affinity for cytochrome B. Pharmaceutical uses of the agents and compositions include treating apoptosis-associated disease, such as neoplasia and drug resistance, are also disclosed.
    Type: Application
    Filed: June 25, 2007
    Publication date: August 13, 2009
    Applicant: Fred Hutchison Cancer Research Center
    Inventors: David M. Hockenberry, Julian A. Simon, Shie-Pon Tzung
  • Mobile Communication Device Providing Integrated Access to Telephony and Internet
    Publication number: 20090147771
    Abstract: Provided are devices, methods, communication managers and user interface solutions that enable access to multiple services from a mobile communications device. A mobile communication device that provides telephony services via a PSTN also includes multiple communication channels that exploit packet data transfer via an IP network, for example enabling VoIP, instant messaging and other internet-based communication services to be initiated from a mobile telephone.
    Type: Application
    Filed: October 13, 2008
    Publication date: June 11, 2009
    Applicant: HUTCHISON WHAMPOA THREE G IP (BAHAMAS) LIMITED
    Inventors: Christopher Henry Seal, Gaetano Vitolo, Kevin David Joyce, Nadir El Yakhlifi
  • Costunolide Derivatives
    Publication number: 20090131427
    Abstract: Disclosed are methods for inhibiting TNF? expression, IL-1? expression, iNOS expression, and NF-?B activity and methods for treating autoimmune disease, cancer, or atherosclerosis with a compound of the following formula:
    Type: Application
    Filed: December 16, 2008
    Publication date: May 21, 2009
    Applicant: HUTCHISON MEDIPHARMA ENTERPRISES LIMITED
    Inventors: Weiguo Su, Hong Jia, Weihan Zhang, Xiaoqiang Yan, Jifeng Duan, Tao Wang, Yu Cai
  • CYTOKINE INHIBITORS
    Publication number: 20090118292
    Abstract: A compound of Formula I: Each variable is defined in the specification. This invention relates to a method of decreasing a level of a cytokine (e.g., TNF? or interlukine such as IL-1?) in a subject with a compound of Formula I. It also relates to a method of treating a disorder mediated by an overproduction of a cytokine with such a compound.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 7, 2009
    Applicant: Hutchison Medipharma Enterprises Limited
    Inventors: Wei Deng, Wei-Guo Su, Yu Cai, Jeff Duan
  • Wireless communication device with casing for audio and/or video player
    Patent number: D594849
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: June 23, 2009
    Assignee: Hutchison Harbour Ring Enterprises Limited
    Inventor: Tung Fei Ko
  • Bluetooth headset
    Patent number: D609698
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: February 9, 2010
    Assignee: Hutchison Harbour Ring Enterprises Limited
    Inventor: Jamie Man Yan Ng
  • Solar charging device
    Patent number: D617264
    Type: Grant
    Filed: August 18, 2009
    Date of Patent: June 8, 2010
    Assignee: Hutchison Harbour Ring Enterprises Limited
    Inventor: Chi Hang Lau
  • Bluetooth earbud
    Patent number: D619566
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: July 13, 2010
    Assignee: Hutchison Harbour Ring Enterprises Limited
    Inventor: Tsz Ying Yu
  • Bluetooth headset
    Patent number: D623629
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: September 14, 2010
    Assignee: Hutchison Harbour Ring Enterprises Limited
    Inventor: Chi Hang Lau